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Pathologic angiogenesis mediated by abnormally
polarized macrophages plays a central role in com-
mon age-associated diseases such as atheroscle-
rosis, cancer, and macular degeneration. Here we
demonstrate that abnormal polarization in older
macrophages is caused by programmatic changes
that lead to reduced expression of ATP binding
cassette transporter ABCA1. Downregulation of
ABCA1 by microRNA-33 impairs the ability of macro-
phages to effectively efflux intracellular cholesterol,
which in turn leads to higher levels of free cholesterol
within senescent macrophages. Elevated intracel-
lular lipid polarizes older macrophages to an
abnormal, alternatively activated phenotype that
promotes pathologic vascular proliferation. Mice
deficient for Abca1, but not Abcg1, demonstrate an
accelerated aging phenotype, whereas restoration
of cholesterol efflux using LXR agonists or miR-33
inhibitors reverses it. Monocytes from older humans
with age-related macular degeneration showed
similar changes. These findings provide an avenue
for therapeutic modulation of macrophage function
in common age-related diseases.
INTRODUCTION
Macrophage-mediated inflammation is causative in several age-
associated diseases, including atherosclerotic heart disease,
cancers, and blinding eye diseases such as age-related macular
degeneration (AMD) (Apte et al., 2006; Kelly et al., 2007; Moore
and Tabas, 2011; Nakao et al., 2005; Niederkorn, 2006). In
atherosclerotic plaques, cholesterol-loaded foam cell macro-Cphages can incite inflammatory rupture of plaques and can
lead to life-threatening cardiovascular complications (Moore
and Tabas, 2011; Tall et al., 2008). In the aged eye, alternatively
activated macrophages can promote pathologic angiogenesis
underneath the retina that leads to blindness (Apte et al., 2006;
Kelly et al., 2007).
ABCA1 and ABCG1 are members of the ATP binding cassette
(ABC) family of transporters and play critical roles in mobilizing
cholesterol out of macrophages and onto extracellular high-
density lipoprotein (HDL). ABCA1 promotes binding of
apolipoproteinA-1 (ApoA-1) to the cell surface, where it solubi-
lizes membrane phospholipid and cholesterol to form nascent
HDL particles in the extracellular space (Vedhachalam et al.,
2007). Unlike ABCA1, ABCG1 cellular localization and its involve-
ment in cholesterol transport are controversial. Although ABCG1
has been identified as a key player in macrophage cholesterol
transport, studies with genetically modified mice revealed that
ABCG1 accounted for little of the cellular cholesterol efflux and
subsequent plasma lipoprotein levels (Kennedy et al., 2005; Na-
kamura et al., 2004; Tarling andEdwards, 2011b). Recent studies
reported that ABCG1 was mainly mobilized to intracellular vesi-
cles of the endosomal pathway to transfer sterols to the plasma
membrane, in contrast to the previous reports of localization of
ABCG1 to the cell membrane (Tarling and Edwards, 2011a).
ABCA1 and ABCG1 may act sequentially, with ABCA1 gener-
ating nascent HDL particles and ABCG1 promoting additional
cholesterol efflux onto HDL, LDL, liposomes, or cyclodextrin, in
a nonspecific manner. In macrophage-specific Abca1-M/-M
mice, there is accumulation of free cholesterol within these cells,
increased lipid rafts content in the plasma membrane, increased
Toll-like receptor 4 in lipid rafts, and increased proinflammatory
activation of macrophages in response to Toll-like receptor ago-
nists (Zhu et al., 2008).
AMD is the leading cause of blindness in elderly individuals
over 50 years of age in the industrialized world. Blindness in
AMD occurs largely from the exudative (wet) form of the disease
that is characterized by the development of abnormal bloodell Metabolism 17, 549–561, April 2, 2013 ª2013 Elsevier Inc. 549
Cell Metabolism
Impaired Cholesterol Efflux Promotes AMDvessels underneath the retina, also called choroidal neovascula-
rization (CNV) (see Figure S1A online) (Klein et al., 2004; van
Leeuwen et al., 2003). Senescent macrophages have been
shown to polarize to a proangiogenic phenotype and promote
the development of CNV (Kelly et al., 2007). Wet AMD is pre-
ceded by nonexudative (dry) AMD. Dry or early AMD is diag-
nosed by the presence of lipid-rich deposits called drusen that
develop external to the retinal pigment epithelium (RPE) under-
neath the retina (Figure S1B). Drusen are cardinal features of
dry AMD (Hageman et al., 2001). Drusen have high lipid content
characterized by esterified-cholesterol-rich apolipoprotein-B-
containing lipoproteins (ApoB-LPs). ApoB-LPs accumulate
within drusen, as has been reported in atherosclerotic plaques
(Curcio et al., 2001, 2005, 2009, 2010; Wang et al., 2010). These
deposits can serve as a nidus for monocytic inflammation (Cur-
cio et al., 2009). Progression of AMD is often characterized by
increased size and number of these lipid-rich drusen (Bressler
et al., 1990). Macrophages have been shown to extend dendritic
processes into drusen, andmacrophage-mediated inflammation
accelerates the conversion of dry to wet form of AMDby promot-
ing blinding pathogenic neovascularization underneath drusen
(Apte et al., 2006; Kelly et al., 2007). Specifically, programmatic
changes in macrophage activation associated with senescence
polarize these cells to a proangiogenic or alternatively activated
phenotype characterized by increased expression of IL-10 and
decreased expression of IL-6 and TNF-a, among others. These
alternatively activated macrophages promote the development
of CNV that leads to progressive loss of vision. The precise
mechanisms by which ‘‘old’’ macrophages polarize to a proan-
giogenic phenotype are yet unknown.
There has been recent interest in the association of cholesterol
regulatory pathways and advanced AMD. Genome-wide associ-
ation studies (GWAS) have demonstrated that single nucleotide
polymorphisms (SNPs) in the innate immune system, specifically
in the complement regulatory pathway, increase the risk of
development and progression of AMD (Edwards et al., 2005).
GWAS have also demonstrated an association between SNPs
in genes involved in cholesterol metabolism and advanced
AMD. These include Abca1, cholesteryl ester transfer protein
(CETP), hepatic triglyceride lipase C (LIPC), and lipoprotein
lipase (LPL) (Chen et al., 2010; Neale et al., 2010). These poly-
morphisms are especially interesting because multivariate ana-
lyses have shown that allelic associations with advanced AMD
are independent of actual serum HDL or lipid levels. It is thus
apparent that the biologic pathways that connect macro-
phage-mediated inflammation, cholesterol regulation, and age
in eye disease and drusen are highly complex and cannot be ex-
plained by a simple association between increased risk and
abnormal serum lipid component levels. We investigated the po-
tential link between abnormal lipid regulation in the senescent
macrophage and its effects on inflammation-driven angiogen-
esis in age-associated eye disease.
RESULTS
Aging-Impaired Macrophage Cholesterol Efflux
Capacity
To determine whether age altered cholesterol efflux in macro-
phages, we analyzed the expression patterns of ABCA1 and550 Cell Metabolism 17, 549–561, April 2, 2013 ª2013 Elsevier Inc.ABCG1 in these cells. Quantitative analysis of gene expression
by real-time PCR demonstrated an age-associated reduction
in levels of ABCA1 and ABCG1 expression in splenic, peritoneal,
and eye macrophages and PBMCs (Figures 1A–1D and Fig-
ure S1C). Analysis of ABCA1 and ABCG1 protein levels in
peritoneal macrophages isolated from either young (<3 months)
or old (>18months) mice bywestern blotting, and flow cytometry
confirmed that reduced gene expression of ABCA1 and ABCG1
with age translated to reduced protein expression (Figures 1E
and 1F).
Because of the critical role of ABC transporters in lipid meta-
bolism in macrophages, we examined whether the age-associ-
ated decrease of ABCA1 and ABCG1 altered the intracellular
lipid load within macrophages and influenced formation of
foam cells. Thioglycollate-elicited young or old peritoneal mac-
rophages were stained with oil red O to visualize foam cells (Fig-
ure 2A, arrow). Quantitative analysis of lipid-laden macrophages
showed that foamy macrophages were more frequent in perito-
neal macrophages collected from old mice as compared to
young mice (Figure 2B). Subsequent quantification of total
cholesterol content by fluorometry confirmed the significantly
increased accumulation of cholesterol in old macrophages
compared to their young counterparts (21.95 ± 0.15 versus
14.90 ± 0.10, p < 0.001) (Figure 2C). To test whether the senes-
cence-associated decrease of ABC transporters affected the
cholesterol efflux efficiency in macrophages, we assessed the
ability of peritoneal macrophages to effectively internalize,
retain, and subsequently efflux lipids from oxidized low-density
lipoproteins (oxLDL). Thioglycollate-elicited young or old perito-
neal macrophages were incubated with Dil-oxLDL for 24 hr,
following which cells were washed and incubated in freshmedia.
Intracellular accumulation of Dil-oxLDL was then examined by
confocal microscopy. Macrophages from old mice had higher
levels of intracellular oxLDL compared to macrophages from
young mice (Figure 2D). In order to assess their abilities to efflux
lipids, young and old macrophages were incubated with Dil-
oxLDL for 3 hr, following which cells were washed and incubated
in fresh media for an additional 21 hr. There was no difference in
the level of internalized oxLDL in young as compared to old
macrophage examined by fluorescence microscopy immedi-
ately after 3 hr of incubation, confirming that the influx capacity
of old macrophages was not altered (data not shown). However,
quantitative analysis of the extruded oxLDL content showed
significantly higher levels in supernatants of youngmacrophages
compared to old cells (Figure S2).
As Dil-oxLDL is not a direct and specific measure of choles-
terol efflux, we next analyzed specific cholesterol efflux of young
and old macrophages preloaded with [3H] cholesterol using
ApoA1 and HDL as carriers. Macrophages were incubated with
5 mCi/ml [3H]cholesterol-labeled oxLDL for 24 hr. Cells were
washed and equilibrated for 1 hr followed by incubation for
4 hr in media containing ApoA1 or HDL. Consistent with the
results above, we demonstrate that cholesterol efflux is signifi-
cantly reduced in old macrophages (Figure 2E). Taken together,
our findings demonstrate that reduced expression of ABC trans-
porters in old macrophages impairs their ability to effectively
efflux cholesterol.
It has been previously demonstrated that macrophages can
sense alterations in extracellular cholesterol levels and
Figure 1. ABCA1 and ABCG1 Expression Is Altered in Senescent Macrophages
(A–C) Quantitative mRNA analysis of ABCA1 and ABCG1 in splenic (A) and peritoneal (B) macrophages and PBMCs (C) isolated from 3-, 12-, or 18-month-old
mice.
(D) CNVwas induced in 3- or 18-month-old mice, and eyemacrophages harvested by laser microdissection were analyzed for ABCA1 and ABCG1 expression by
qPCR.
(E) Whole-cell lysates of peritoneal macrophages of 3- or 18-month-old mice were subjected to immunoblot analysis with antibodies against ABCA1, ABCG1, or
b-actin.
(F) Relative flow cytometry profiles of ABCA1 and ABCG1 in peritoneal macrophages isolated from 3- or 18-month-old mice. Iso, negative isotype control.
Values are expressed as mean + SE (A–D). Statistically significant difference, *p < 0.05, **p < 0.01, ***p < 0.001.
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2000). We next investigated the effect of cholesterol treatment
on the expression patterns of ABCA1/G1 in young or old macro-
phages. Youngmacrophages demonstrated a robust increase in
expression of both ABCA1 and G1 after incubation with oxLDL,
while old macrophages were significantly impaired in their ability
to do so (Figures 2F and 2G). These findings confirm that senes-
cent macrophages not only have reduced cholesterol efflux
capacities but also are unable to respond to exogenous lipid
as efficiently as young macrophages.
In response to microenvironmental signals, macrophages
have been shown to exhibit classic (M1) or alternative (M2) acti-
vation characterized by differential cytokine production, recep-
tor expression, and effector function (Mantovani et al., 2004;
Mosser, 2003). We examined whether defective cholesterol
efflux promoted a specific macrophage activation phenotype.
In young and old macrophages, the gene expression profile of
M1 (TNF-a, IL-6, IL1b, PTGS2, CCL2, and MMP9) and M2
(IL-10, CD163, and TGF-b) markers was assessed by real-time
PCR. As shown in Figure 2H, expression of M1 markers was
significantly reduced in old as compared to youngmacrophages,
whereas expression of M2 markers IL-10 and CD163 was signif-
icantly upregulated. These results clearly indicate that senescentCmacrophages are alternatively activated and associated with an
anti-inflammatory profile.
Abca1, Not Abcg1, Depletion Affected Macrophage
Regulation of Vascular Endothelial Cell Proliferation and
Pathological Angiogenesis
To determine the contribution of individual ABC transporters in
age-associated dysfunction of macrophage cholesterol homeo-
stasis, we investigated the effects of selective Abca1 or Abcg1
deletion on effector function. Recent studies have demonstrated
that macrophage polarization can play a pivotal role in deter-
mining their ultimate effector functions, including their ability to
regulate angiogenesis (Apte et al., 2006; Kelly et al., 2007; Man-
tovani et al., 2005; Mosser, 2003). To determine whether Abca1
or Abcg1 deletion affected macrophage polarization, we
analyzed the gene expression patterns of peritoneal macro-
phages isolated from young wild-type (WT), Abca1-M/-M, or
Abcg1/ mice by quantitative real-time PCR. Loss of Abca1
was associated with a significant decrease in IL-6, IL1b,
PTGS2, and MMP9 expression and an upregulation of IL-10
expression, consistent with an alternatively activated phenotype
(Figure 3A). Expression levels of TNF-a and IL-12 were not
altered (data not shown). As previously shown, this geneell Metabolism 17, 549–561, April 2, 2013 ª2013 Elsevier Inc. 551
Figure 2. Age-Associated Impairment in Macrophage Cholesterol Efflux Capacities
(A and B) (A) Thioglycollate-elicited young or old peritoneal macrophages were stained with oil red O and hematoxylin, and (B) quantitative analysis of foamy
macrophages was performed.
(C) Total cholesterol content of young or old macrophage was measured and normalized to protein content.
(D) Peritoneal macrophages were incubated with DiI-oxLDL, and intracellular accumulation of oxLDL was assessed by confocal microscopy.
(E) Cholesterol efflux to ApoA1 and HDL of peritoneal macrophages preloaded with [3H]cholesterol-oxLDL.
(F and G) Peritoneal macrophages isolated from 3-, 12-, or 18-month-old mice were treated with 25 mg/ml oxLDL, and relative mRNA expression of ABCA1 (F)
and ABCG1 (G) was determined.
(H) Young and old macrophage polarization. Expression of M1 (TNF-a, IL-6, IL1b, PTGS2, CCL2, and MMP9) and M2 (IL-10, CD163, and TGF-b) markers was
analyzed by qPCR.
Values are expressed as mean + SD (B) and mean + SE (C and E–H). Statistically significant difference, *p < 0.05, **p < 0.01, ***p < 0.001.
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phages (Apte et al., 2006; Mantovani et al., 2005; Mosser,
2003). In contrast, loss of Abcg1 had no effect on global macro-
phage polarization to either classical or alternatively activated
cells, as both IL-6 gene expression and IL-10 gene expression
were reduced significantly (Figure S3A).
Next, we investigated the ability of Abca1-M/-M and Abcg1/
macrophages to inhibit vascular endothelial cell proliferation
in vitro using HMVECs and to regulate pathologic angiogenesis
in vivo using the injury-induced CNV assay, as described previ-
ously and in the Experimental Procedures (Kelly et al., 2007). In
cocultures, Abca1-M/-Mmacrophages from young mice lost their
ability to inhibit HMVECs proliferation as compared to macro-
phages from age-matched WT mice or from Abcg1/ young
macrophages (Figure 3B and Figure S3B). These results, com-
bined with previous findings that old macrophages lose the abil-
ity to regulate vascular proliferation and CNV, suggest that
Abca1-M/-M macrophages demonstrate an accelerated senes-
cence program. We investigated this in vivo in the injury-induced
CNV model. As anticipated, CNV volumes were significantly
higher in mice whose macrophages were deficient in Abca1 as
compared to WT littermates (Figures 3C and 3D). In contrast,
CNV volumes in Abcg1/ mice were comparable to littermate
controls, confirming an ability of these cells to inhibit CNV (Fig-
ures S3C and S3D). We next explored whether loss of Abca1
in macrophages altered the expression of VEGF, a well-docu-
mented angiogenic factor that promotes endothelial cell growth.
Analysis of VEGF production by WT and Abca1-M/-M macro-
phages by ELISA revealed that there was no significant differ-
ence (Figure S3E). Our findings suggest that the proangiogenic
phenotype of ABCA1-deficient macrophage is VEGF indepen-
dent. Taken together, these results demonstrate that ABCA1 is
the primary regulator of macrophage polarization and that
‘‘young’’ macrophages lacking Abca1 have the same cytokine
polarization and functional deficits, i.e., proangiogenic behavior,
as ‘‘old’’ WT macrophages.
Cholesterol-Rich Diet Accelerated a Senescent
Macrophage Phenotype
As shown in Figure 2, ABCA1/G1 transporters within macro-
phages regulate intracellular cholesterol efflux. We next investi-
gated the effect of chronic dietary lipid/cholesterol burden on
macrophage function using diet-induced obesity (DIO) mice as
a model of high-fat/cholesterol-fed mice. Quantitative analysis
of intracellular cholesterol content demonstrated that DIO mac-
rophages had significantly higher levels of total cholesterol
compared to age-matched controls at both 3 and 6 months of
age (Figure 3E). To determine whether high fat/cholesterol stress
altered the ability of DIO macrophages to regulate vascular pro-
liferation, we incubated young DIO macrophages with HMVECs
and assessed their proliferation. DIO macrophages were unable
to inhibit HMVECs proliferation (Figure 3F). In addition, DIOmac-
rophages demonstrated an impaired ability to regulate CNV
in vivo (Figures 3G and 3H), indicating that chronic fat/choles-
terol stress can impair the ability of macrophages from young
mice to regulate pathological vascular proliferation and angio-
genesis. Quantification of plasma lipid and cholesterol levels
showed an increase in 3-month-old DIO mice as compared to
controls (FFA, 0.77 ± 0.044 versus 0.52 ± 0.008 mM; TG,C67.5 ± 12.9 versus 32.5 ± 3.9 mg/dl; cholesterol, 132.3 ± 13.6
versus 109.1 ± 2.8 mg/dl). These data also suggest that higher
dietary lipid can potentially accelerate the programmatic
changes associated with senescence within macrophages.
Enhancing Efflux in Senescent Macrophages Restored
Their Functional Capacity to Regulate Pathological
Angiogenesis
Our data show that age-associated reduction in expression of
ABC transporters impairs the efflux capacity of macrophages
and results in increased cholesterol accumulation. Loss of
Abca1 also translated into a loss of the ability of these cells to
regulate angiogenesis. We therefore investigated whether
restoring the efflux capacity of macrophages in old mice could
improve their effector functions. Recent studies have shown
that transcriptional nuclear receptors such as liver X receptors
(LXRs) were direct enhancers of ABC transporter expression in
macrophages (Repa et al., 2000).
Treatment of peritoneal young or old macrophages with LXR
synthetic agonist (T0-901317) induced a dose-dependent upre-
gulation of both ABCA1 and ABCG1 gene expression (Figures 4A
and 4B). Treatment of old macrophages with LXR agonists al-
lowed old cells to reach (at lower doses of agonist) and even
exceed (at higher doses) the expression levels of ABCA1 seen
in young macrophages. Increased expression of ABCG1 in old
macrophages after treatment with LXR agonist was comparable
to that seen in young macrophages.
Although the ability of old macrophages to upregulate ABCA1/
G1 transporter expression in response to exogenous cholesterol
(oxLDL) was dampened, as seen in Figures 2F and 2G, they were
able to respond robustly to direct LXR stimulation by synthetic
ligand (T0-901317). It has been previously demonstrated that
LXR can be regulated by endogenously synthesized cholesterol
oxidation products (oxysterols) such as 27-hydroxycholesterol
(27-HC) or nonoxysterol mediators (T0-901317) (Janowski
et al., 1996; Repa and Mangelsdorf, 1999; Repa et al., 2000).
An analysis of cell-associated oxysterol content of young and
old macrophages at baseline showed a 2-fold increase in 27-
HC in old macrophages (Figure 4C). The increase in 27-HC
was accompanied by a commensurate 2-fold increase in 7-keto-
cholesterol (7-KC). While 27-HC is an activator of the LXR
pathway (Fu et al., 2001), numerous studies have shown that
7-KC can effectively interfere with LXR activation and cholesterol
efflux (Gelissen et al., 1996, 1999; Kritharides et al., 1995). As
seen in Figure 4C, the absolute increase in 7-KC levels was
17-fold greater than that of 27-HC, offering a possible explana-
tion as to why old macrophages are unable to respond as effi-
ciently to exogenous cholesterol stimulation but respond
robustly to synthetic agonists.
These data suggest that it might be possible to reverse some
of the programmatic dysfunctionality seen in these cells with
age. In order to confirm this hypothesis, we cocultured LXR
agonist (T0-901317)-treated young or old macrophages with
HMVECs and analyzed their ability to inhibit endothelial cell pro-
liferation. As shown in Figure 4D, LXR agonist treatment of old
macrophages completely restored their ability to inhibit endothe-
lial cell proliferation. Treatment of Abca1-M/-Mmacrophages with
LXR agonist does not restore their ability to inhibit HMVECs pro-
liferation (Figures S4A and S4B). Interestingly, both young andell Metabolism 17, 549–561, April 2, 2013 ª2013 Elsevier Inc. 553
Figure 3. Macrophage Ability to Regulate Vascular Proliferation Is Altered by Abca1 Deletion or Cholesterol-Rich Diet
(A) Quantitative mRNA analysis of M1 (TNF-a, IL-6, IL1b, PTGS2, CCL2, and MMP9) and M2 (IL-10, CD163, and TGF-b) markers in WT (Abca1+M/+M) and Abca1-
deficient (Abca1-M/-M) peritoneal macrophages.
(B) HMVECs proliferation when cocultured with Abca1+M/+M or Abca1-M/-M macrophages.
(C) Abca1+M/+M or Abca1-M/-M mice were perfused with FITC-dextran (green) 7 days after laser injury, and CNV was examined by confocal microscopy.
Representative CNV photographs are shown; scale bar, 100 mm.
(D) Quantification of CNV (white circle) demonstrated a significant increase of CNV volume in Abca1-M/-M mice compared to WT mice.
(E) Quantification of relative cholesterol content demonstrated a higher accumulation in macrophages from DIOmice at both 3 and 6months of age as compared
to controls.
(legend continued on next page)
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pound) exhibit features of classically activated M1 phenotype
(Figure S4C).
These results confirm that downregulation of ABCA1 (not
ABCG1) is the basis of the impaired function observed in old
macrophages.
Old mice were then treated with intraperitoneal injections of
vehicle (DMSO) or T0-901317 at 25 or 50 mg/kg/day for 5 days
prior to laser induction of CNV. Quantitative analysis of gene
expression showed that treated mice at both doses had strong
systemic upregulation of ABCA1 and ABCG1 expression
compared to vehicle-treated mice (Figures 4E–4G and Figures
S4D and S4E). In addition, LXR-agonist treatment of old mice re-
sulted in a significant and dose-dependent reduction in CNV
compared to vehicle-treated old mice, thus restoring their func-
tional capacity to regulate pathological vascular proliferation
(Figures 4H and 4I). We further investigated whether local
enhancement of macrophage efflux capacities can improve their
regulation of CNV. Old mice were pretreated for 7 days with eye
drops of vehicle or 4 mM of T0-901317 prior to induction of CNV.
Quantitative analysis of ABCA1 and ABCG1mRNA levels, after 7
additional days of eye drops treatment, showed a significant
increase in the retina, brain, and liver (Figures S4F–S4I) of LXR
agonist-treated mice as compared to vehicle-treated mice. Our
findings also demonstrate that local LXR agonist treatment is
as effective as systemic administration, given the fact that CNV
volume is significantly reduced in oldmice treatedwith eye drops
of T0-901317 compared to vehicle (Figures S4J and S4K).
Taken together, these results conclusively demonstrate that
direct induction of cholesterol efflux with synthetic LXR agonists
locally or systemically restores in old macrophages effector
capabilities that are similar to those observed in young
macrophages.
Age-Related Reduction of ABCA1 Expression in Human
PBMCs
The above data clearly demonstrate that senescent macro-
phages have impaired cholesterol efflux capacities that lead
to a loss of their ability to regulate vascular proliferation. This
impairment in macrophage function is associated with a loss
of ABCA1. We next investigated the expression levels of
ABCA1/G1 in PBMCs isolated from young (age range 25–34
years, n = 9) and old (age range 67–87 years, n = 9) donors. Total
protein extracts were analyzed for ABCA1/G1 expression, and
representative immunoblots are shown in Figure 5A. Densito-
metric analysis normalized to b-actin expression showed that
ABCA1 expression level was significantly reduced in old
compared to young donors, while ABCG1 protein expression
was unchanged (Figures 5B and 5C). These findings are consis-
tent with quantitative gene expression analysis demonstrating
that ABCA1 gene expression was 2.5-fold lower in old donors
while ABCG1 expression was not significantly different (Figures
S5A and S5B). In addition, PBMCs from old donors had higher
levels of IL-10, CD163, and IL8 expression compared to young(F) Measurement of proliferation of HMVECs after incubation with DIO or control
(G and H) Representative illustration (G) and quantification of CNV (white circle)
compared to controls.
Values are expressed as mean + SE. Statistically significant difference, **p < 0.0
Cdonors, confirming their phenotype as alternatively activated
cells (Figure S5C).
Immunohistochemistry of a CNV membrane isolated from a
patient during subretinal surgery confirmed the presence of
CD68-positive macrophages that have reduced ABCA1 expres-
sion when compared to other cell types within the lesion (Fig-
ure 5D, arrows).
Age-Related Overexpression of miR-33 Repressed
Macrophage Regulation of Vascular Proliferation
We have shown that aging altered macrophage expression of
ABCA1 and ABCG1 that resulted in defective cholesterol efflux
and subsequent impairment in their capacity to regulate patho-
logical angiogenesis. We next investigated the mechanisms
that led to the age-associated decline in the expression of
ABC transporters. To determine whether epigenetic mecha-
nismswere involved in this process, we analyzed themethylation
pattern of Abca1 and Abcg1 promoters by bisulfate-modified
CpG Sanger sequencing. There was no significant difference in
the frequency or pattern of methylation of the promoter regions
of these genes between young and old macrophages (Fig-
ure S6A). Recent studies have shown that a highly conservedmi-
croRNA, miR-33, regulates the expression of genes involved in
cellular cholesterol metabolism, among them ABCA1 and
ABCG1(Marquart et al., 2010; Najafi-Shoushtari et al., 2010;
Rayner et al., 2010, 2011). We next examinedmiR-33 expression
in young and old macrophages. As shown in Figure 6A, miR-33
expression was significantly higher in old macrophages as
compared to young, consistent with reduced expression of
ABCA1 and ABCG1 observed in aged macrophages. Analysis
of miR-33 and its host gene, SREBP-2, expression revealed
that in both young and old macrophage, miR-33 and SREBP-2
are coexpressed and coordinately regulated after LXR agonist
treatment or cholesterol loading (Figures S6B–S6D). Based on
these findings, we hypothesized that antagonism of miR-33 in
macrophagesmight enhance their regulation of vascular prolifer-
ation. Macrophages were transfected with LNA miR-33 inhibitor
(anti-miR-33) or negative control inhibitor (con anti-miR), and
expression of ABC transporters was assessed. MicroRNA effi-
cient transfection delivery was confirmed using fluorescent
LNA anti-miR, as shown in Figure 6B. Inhibition of miR-33 in
young and old macrophages resulted in a significant increase
in mRNA and protein levels of ABCA1 (Figures 6C and 6D). In
addition, antagonism of endogenous miR-33 not only promoted
the polarization of macrophages to M1 phenotype (Figures S6E
and S6F) but also improved the ability of young and old macro-
phages to inhibit vascular endothelial cell proliferation
(Figure 6E). More importantly, improvement of the ability of mac-
rophages to regulate vascular proliferation is ABCA1 dependent,
as the inhibition of miR-33 in Abca1-M/-M macrophages had no
effect on their regulation of endothelial cell proliferation (Fig-
ure S6G). So far we have show that macrophages from old
mice exhibit impaired regulation of CNV in vivo and vascular
endothelial cell proliferation in vitro. As these effects aremacrophages.
volume (H) demonstrated an inability of DIO macrophages to inhibit CNV as
1, ***p < 0.001.
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Figure 4. LXR Agonist Treatment Restored the Functional Capacities of Senescent Macrophages
(A and B) Peritoneal macrophages isolated from young and old mice were treated with vehicle, 1 nM to 10 mM of T0-901317 (T0), and quantitative analysis of
ABCA1 (A) and ABCG1 (B) gene expression was performed by real-time qPCR.
(C) Oxysterols (27-hydroxycholesterol [27-HC] and 7-ketocholesterol [7-KC]) extracted from culture medium of young or old peritoneal macrophages were
quantified by HPLC/MS and normalized to macrophage protein content.
(D) Effect of T0-901317 treatment on the ability of macrophages to inhibit HMVECs proliferation.
(E–G) Quantitative mRNA levels of ABCA1 and ABCG1 in retina (E), choroid (F), and peritoneal macrophages (G) of old mice, treated for 5 consecutive days with
vehicle, 25 mg/kg, or 50 mg/kg of T0-901317.
(H and I) (H) Representative CNV images in vehicle and LXR agonist-treated old mice and quantification (I) of CNV (white circle) volume show a dose-dependent
reduction of endothelial cell proliferation.
Values are expressed as mean + SE. Statistically significant difference, *p < 0.05, **p < 0.01, ***p < 0.001, compared to vehicle treatment.
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silencing of miR-33 could restore macrophage function and their
ability to inhibit CNV. Old mice were pretreated daily with intra-
peritoneal injection of 10 mg/kg LNA negative control anti-miR556 Cell Metabolism 17, 549–561, April 2, 2013 ª2013 Elsevier Inc.or anti-miR-33 for 7 days prior to induction of CNV. After an addi-
tional 7 days of treatment, the quantitative mRNA analysis re-
vealed that ABCA1 level was significantly higher in the choroid
(Figure 6F) and retina (Figures S6H and S6I) of old mice treated
Figure 5. Age-Related Alteration of ABCA1 Expression in Human PBMCs
(A–C) (A) Western blot analysis of proteins extracted from PBMCs of young (<35 years old) or old (>65 years old) donors. Immunoblots were probed with an-
tibodies against ABCA1, ABCG1, or b-actin. Relative quantification of ABCA1 (B) and ABCG1 (C) band densities.
(D) Immunohistochemistry of a CNV sample isolated from a patient after subretinal surgery with antibodies against ABCA1 (green) or CD68 (macrophage marker,
red). Nuclei were stained with Draq5 (blue). Values are expressed as mean + SE. Statistically significant difference, *p < 0.05.
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Impaired Cholesterol Efflux Promotes AMDwith anti-miR-33 compared to control-treated mice. In addition,
inhibition of miR-33 also induced a significant increase of ABCA1
protein levels (Figure 6G). As shown in Figures 6H and 6I, antag-
onism of miR-33 in old mice resulted in significantly decreased
CNV compared to control-treated old mice.
DISCUSSION
Clear parallels exist between atherosclerosis and AMD. Athero-
sclerosis is characterized by subvascular endothelial ApoB-LP
focal deposition in the form of plaques (Moore and Tabas,
2011). AMD is characterized by the development of subretinal
drusen, which are highly enriched for esterified-cholesterol rich
ApoB-LP (Curcio et al., 2010). Macrophage-mediated plaque
progression and inflammation can eventually lead to plaque ne-
crosis, rupture, and death. In AMD, chronic age-associated
changes program macrophages to a disease-promoting proan-
giogenic phenotype that renders these cells unable to regulate
the growth of abnormal blood vessels within the central retina
called the macula (Kelly et al., 2007; Klein et al., 2004). These
aberrant vessels are responsible for bleeding that can lead to se-
vere vision loss and blindness. Although macrophages have
been shown to interact with and process lipid-rich material in
drusen, the precise molecular mechanisms that cause senes-
cent macrophages to promote progression from drusen to neo-
vascularization in the eye were previously unknown.
In these studies, we have demonstrated that the cholesterol
efflux regulators ABCA1 and ABCG1 are downregulated in mac-
rophages with age in both mice and humans. Age-associated
downregulation of ABCA1 leads to alternative proangiogenic po-
larization of macrophages to an M2-like disease-promoting
phenotype. This is especially interesting in the light of previous
studies that have shown that older mice have significantly higher
volumes of CNV (Kelly et al., 2007) after injury and that advanced
AMD (van Leeuwen et al., 2003) characterized by CNV only de-
velops in individuals over 50 years of age. Using loss-of-functionCexperiments with conditional knockout mice, we have been able
to demonstrate that macrophages deficient in ABCA1 are unable
to regulate CNV in vivo and vascular endothelial cell proliferation
in vitro. In essence, Abca1-M/-M macrophages functionally
behave like senescent macrophages isolated from mice at least
18 months of age. Of interest, loss of Abcg1 does not seem to
affect the ability of these cells to regulate CNV or vascular endo-
thelial proliferation, suggesting a dominant role for ABCA1 in this
process. In addition, our results also suggest that these effects
are VEGF independent. A potential reason for the ABCA1 domi-
nance in this process is the complete polarization of Abca1-M/-M
macrophages to an M2 phenotype identical to that seen in se-
nescent macrophages that are unable to regulate aberrant
angiogenesis. By contrast, Abcg1/ macrophages have a
mixed phenotype, which may explain why they retain their func-
tional abilities and do not demonstrate a programmatic shift to a
senescent phenotype. It is also possible that ABCA1-driven
efflux of intracellular cholesterol to the cell surface prior to depo-
sition on to lipid-poor ApoA-1 is the critical pathway involved in
the ability of macrophages to regulate aberrant and proliferative
angiogenesis.
Experiments in DIO mice have also provided insights into the
effects of cholesterol loading on macrophage function in the
eye. Macrophages from mice fed a high-fat diet for a period of
up to 6 months are unable to regulate CNV in vivo and vascular
endothelial cell proliferation in vitro. These findings shed light on
conflicting data from genetic and epidemiologic studies that
demonstrate a complex association between polymorphisms
in genes that regulate HDL and cholesterol metabolism and
AMD as outlined above (Chen et al., 2010; Neale et al., 2010).
The data from knockout mice and the reduced expression of
ABC transporters from old humans, diagnosed with AMD, sug-
gest that local regulation of cholesterol efflux in the eye and
the ability of macrophages to efficiently transport cholesterol
from drusen to HDL and onto the systemic circulation are critical
for the prevention of triggering of drusen-induced CNV in AMD.ell Metabolism 17, 549–561, April 2, 2013 ª2013 Elsevier Inc. 557
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efflux cholesterol efficiently. This leads to alternative proangio-
genic polarization of these cells, which in the appropriate genetic
context of polymorphisms in complement regulatory genes (Ed-
wards et al., 2005), and alongside environmental cues such as
smoking, can create a lethal micromilieu for the development
and progression of advanced AMD where new blood vessels
proliferate, cause bleeding, and induce the formation of scar tis-
sue that leads to photoreceptor loss and blindness. Cholesterol-
loading experiments with DIO mice suggest that this process
may be modified and accelerated by dietary lipid.
Our gain-of-function studies demonstrate that by upregulating
ABC transporter expression in senescent macrophages using
LXR agonists, we are able to restore their ability to inhibit
vascular endothelial cell proliferation and CNV. In essence,
LXR agonists are able to reverse the senescent phenotype and
restore their angioregulatory function to levels comparable to
mice that are significantly younger. Our work also revealed that
upregulation of miR-33 in aged macrophages might be respon-
sible for the repression of ABCA1 that leads to defective cellular
cholesterol metabolism in senescent macrophages. We have
shown that despite increased cholesterol accumulation in old
macrophages, SREBP-2/miR-33 levels were higher when
compared to young macrophages. Such cholesterol accumula-
tion translated into a significant increase of production of diverse
oxysterols with potentially different effects on cholesterol efflux
and transport. Indeed, antagonism of endogenous miR-33 im-
proves macrophage regulation of vascular proliferation and
silencing of miR-33 in old mice, and results in specific and robust
inhibition of CNV. Anti-miR-33 treatment polarizes macrophages
to a classically activated phenotype that is reflected in the cyto-
kine gene expression signature. These results have significant
therapeutic implications. CNV in AMD accounts for a large ma-
jority of blindness from this disease. Therapeutic intervention
prior to the development of advanced disease with effective
agents that upregulate macrophage cholesterol efflux in the
eye might prevent progression and can be used as prophylaxis
against the development of CNV and its blinding complications.
The ability to deliver such therapies locally to the eye is a unique
advantage in this immune-privileged organ (Niederkorn, 2006)
and may be an effective barrier to off-target complications that
are often seen with systemic therapy.
EXPERIMENTAL PROCEDURES
Animals
All animal experiments were conducted in accordance with Washington Uni-
versity School of Medicine in St. Louis Animal Care and Use guidelines and af-Figure 6. miR-33 Modulates Macrophage Regulation of Vascular Proli
(A) Quantitative analysis of miR-33 in young and old peritoneal macrophages.
(B) Representative photograph of macrophages untransfected (UT) or transfected
mice were transfected with negative control anti-miR or anti-miR-33.
(C and D) Twenty-four hours after transfection, mRNA (C) and protein (D) expres
(E) Effects of miR-33 antagonism on macrophage inhibition of HMVECs prolifera
(F and G) Old mice were pretreated daily with 10 mg/kg in vivo LNA, negative con
then treated for 7 additional days, and quantitative mRNA (F) and protein (G) lev
(H and I) Representative illustration (H) and CNV volume quantification (I) showed
cell proliferation.
Values are expressed as mean + SE. Statistically significant difference, *p < 0.05
Cter approval by the Animal Studies Committee. C57BL/6 mice (aged
<6 months), diet-induced obese (DIO) mice, and age-matched controls were
purchased from The Jackson Laboratory. C57BL/6 old mice (aged
>18 months) were purchased from National Institute of Aging. Macrophage-
specific Abca1 knockout mice (Abca1-M/-M) were generated by breeding
Abca1flox/flox mice, provided by Dr. John S Parks (Timmins et al., 2005), with
Lys-M Cre mice (The Jackson Laboratory). Previously characterized
Abcg1/ knockout mice (Balda´n et al., 2006; Kennedy et al., 2005) were pro-
vided by Dr. Angel Balda´n.
Cells
Splenic macrophages were isolated by positive selection as previously
described (Apte et al., 2006). In brief, F4/80+ macrophages were purified
from dissociatedmouse spleen usingmagnetic separation (StemCell Technol-
ogies, Inc. Inc.). Peritoneal macrophage recruitment was elicited by intraperi-
toneal injection of 4% thioglycollate. Five days after injection, macrophages
were harvested and cultured in RPMI-1640 overnight (GIBCO). Young or old
mouse peripheral blood mononuclear cells (PBMCs) were prepared by
centrifugation over Histopaque 1083 (Sigma-Aldrich) according to the manu-
facturer’s instructions. Single-eyemacrophages were isolated fromCNV com-
plexes (Figure S1C) by laser capture microdissection (LMD6000, Leica).
Human dermal microvascular endothelial cells (HMVECs) were purchased
from Lonza and cultured in EGM2V media. Human peripheral blood mononu-
clear cells were isolated from young (age range 25–34 years, n = 9) or old (age
range 67–87 years, n = 9) donors diagnosed with neovascular AMD. This study
was approved by the Human Research Protection Office of Washington Uni-
versity School of Medicine in St. Louis School, and informed consent was
obtained from all blood donors. PBMCs were purified by density gradient
centrifugation using BD Vacutainer CPT.
Real-Time PCR and Gene Expression Analysis
Total RNA was prepared from splenic macrophage, peritoneal macrophages,
retina, choroid, or PBMCs using the RNeasyMini Kit (QIAGEN). cDNAwas pre-
pared using the High Capacity cDNA Archive Kit (Applied Biosystems), and
PCR amplifications of cDNA were performed using Taqman probe-based
gene expression assay (Applied Biosystems) as previously described (Kelly
et al., 2007).
Cholesterol Measurement
Total cholesterol content of young and old peritoneal macrophages was quan-
tified using the Amplex Red Cholesterol Assay Kit (Molecular Probes). In brief,
50 ml of cell lysates (diluted in reaction buffer supplied in the assay kit) were
incubated with 50 ml of the Amplex Red reagent/HRP/cholesterol oxidase/
cholesterol esterase solution for 30 min at 37C. At different time points,
cholesterol-associated fluorescence was measured, and total cholesterol
content was quantified using a cholesterol standard curve.
OxLDL Uptake Assay
Peritoneal macrophages isolated from young (<3 months) and old
(R18 months) mice were plated on chamber slides, and adherent cells were
treated with 25 mg/ml Dil-oxydized LDL (oxLDL) for 24 hr (Intracel). After mul-
tiple washes, Dil-oxLDL retention was examined using Zeiss LSM510 confocal
microscope.feration
with fluorescent LNA anti-miR. Macrophages isolated from 3- or 18-month-old
sion of ABCA1 were determined.
tion.
trol anti-miR, or anti-miR-33 for 7 days prior to induction of CNV. (F) Mice were
el of ABCA1 in the choroid were analyzed.
that in vivo antagonism of miR-33 induced an inhibition of vascular endothelial
, **p < 0.01.
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Thioglycollate-elicited peritoneal macrophage from young (<3months) and old
(R18 months) mice were incubated with 5 mCi/ml [3H]cholesterol-labeled
oxLDL for 24 hr. Cells were then washed and equilibrated with 2 mg/ml BSA
(Sigma-Aldrich) in media for 1 hr followed by incubation for 4 hr in media con-
taining 10 mg/ml human ApoA1 or 50 mg/ml human HDL. Supernatants were
collected, and specific ApoA1/HDL-cholesterol efflux was expressed as a per-
centage relative to total radioactivity in cells and media.
Serum Analyses
Serum levels of lipids and cholesterol were determined as previously
described (Chakravarthy et al., 2005). Mice were anesthetized, and blood
was collected from the retro-orbital venous plexus with a capillary tube. Serum
concentrations of free fatty acids (FFAs), triglycerides (TGs), and cholesterol
were determined enzymatically using kits purchased from Sigma-Aldrich.
Vascular Endothelial Cell Proliferation Assay
Cell proliferation was measured with an adaptation of a previously described
method (Khan and Apte, 2008). HMVECs (1 3 104 cells) in log phase were
cultured in 96-well round-bottomed plates for adherence. HMVECS cells
were then cocultured with peritoneal macrophages (1:25 ratio) and incubated
with 5 mCi/ml [3H] thymidine (PerkinElmer) for 24 hr. Cells were harvested onto
glass fiber filters (Packard), and incorporated [3H] thymidine was read using
TopCount NXT (PerkinElmer).
Laser-Induced CNV in Mice
Rupture of Bruchs membrane with laser was used to initiate CNV in mice as
described previously (Apte et al., 2006). Although this is an injury model of
AMD, it has been highly predictive of the pathophysiology of and molecular
mechanisms underlying neovascular AMD. Briefly, mice were anesthetized,
and their pupils were dilated with 1% tropicamide. Using argon green laser,
four laser burns were placed around the optic nerve (0.1 s, 50 mm, and
110 mW). Seven days after laser, mice were anesthetized and perfused intra-
ventricularly with FITC-dextran (Sigma-Aldrich). Mice were euthanized in a
CO2 chamber, and their eyes were harvested for tissue processing. The
choroidal flat mounts were analyzed for the presence of CNV by confocal mi-
croscopy. The extent of CNV was quantified by Metamorph Imaging software.
We used nR 5 mice for each group.
LXR Agonist Treatment
Young and old peritoneal macrophages were treated with LXR agonist, T0-
901317 (Sigma-Aldrich), for 24 hr. LXR agonist was dissolved in DMSO
(vehicle), and treatment dosage ranged from 0 to 10 mM.Oldmice (>18months)
were given a daily intraperitoneal injection of vehicle, 25mg/kg or 50mg/kg T0-
901317. After 5 consecutive days of treatment, CNV was induced and
analyzed as described above. Old mice were pretreated for 7 consecutive
days with eye drops of vehicle or 4 mM T0-901317 prior to induction of
CNV. After 7 additional days of eye drops treatment, CNV volume was quan-
tified, and mRNA levels of ABCA1 and ABCG1 were analyzed in mouse
tissues.
Oxysterol Determinations
Oxysterols were extracted fromRPMI-1640 culture media of young or old peri-
toneal macrophages, and determinations of 27-hydroxycholesterol (27-HC)
and 7-ketocholesterol (7-KC) were performed as previously described (Jiang
et al., 2011).
MicroRNA Quantification
Total miRNA was isolated from peritoneal macrophages using mirVana kit
(Ambion) and reverse transcribed with the RT2 miRNA First Strand Kit
(SABioscience). PCR amplifications of cDNA were performed using RT2
SYBR Green qPCR (SABioscience) with specific primers for quantification of
mouse miR-33 and normalized to U6 as housekeeping gene.
Antagonism of miR-33
Peritoneal macrophages were transfected with 50 nM LNA (locked nucleic
acid) miR-33 inhibitor (anti-miR-33) or negative control inhibitor (con anti-
miR) (Exiqon) using HiPerFect Transfection reagent (QIAGEN). The transfec-560 Cell Metabolism 17, 549–561, April 2, 2013 ª2013 Elsevier Inc.tion efficiency of macrophages was assessed using fluorescent LNA anti-
miR (Exiqon). After miR-33 inhibition, target genes and proteins were analyzed
by qPCR and western blotting.
Old mice were pretreated for 7 days with daily intraperitoneal injection of
10 mg/kg in vivo LNA anti-miR-33 or control anti-miR (Exiqon), prior to induc-
tion of CNV. After 7 additional days of treatment, CNV volume was quantified,
and the expression of miR-33 targets was analyzed in mouse tissues by qPCR
and western blotting.
Statistics
Statistical analysis was determined by two-tailed Student’s t test and ANOVA
with the use of GraphPad Prism Software. The error bars represent standard
SEM, except in Figure 2B, where errors bars represent SD. Statistical signifi-
cance was defined at p < 0.05.
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